Stock Events

Stock Events

CRISPR Therapeutics (1CG.STU) Q2 2026 Earnings

4MayConfirmed

Q1 2026

Q2 2026

-1.15

-1.1

-1.04

-0.98

Details

Expected EPS

-1.04218924783

Actual EPS

-1.0947968000000001

Surprise EPS

-0.05

Surprise Percent

+5.05%

Description

CRISPR Therapeutics (1CG.STU) has reported earnings of -1.0947968000000001 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.